Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Lifeway Foods, Inc. (NASDAQ: LWAY), an Illinois-based manufacturer of probiotic, cultured and fermented dairy foods. Through these filings, investors can review how the company reports financial performance, governance changes and key agreements that affect LWAY common stock.
Recent Form 8-K current reports document a range of material events. One 8-K dated November 12, 2025 furnishes five-year financial projections that Lifeway provided to Danone North America PBC during due diligence for a potential transaction, including net sales, gross profit, operating income, Adjusted EBITDA, capital expenditures and free cash flow. Other 8-Ks disclose estimated unaudited net sales for a fiscal quarter, the execution of a Cooperation Agreement with Danone, the appointment and resignation of directors, and the scheduling of annual shareholder meetings.
Filings also describe governance and rights arrangements. An 8-K dated October 29, 2025 outlines Amendment No. 1 to the Shareholder Rights Agreement, extending the expiration of a shareholder rights plan and explaining the board’s rationale related to concentrated share ownership and potential accumulation of control without a premium. Another 8-K filed September 30, 2025 details the Cooperation Agreement with Danone, including board refreshment, voting commitments and registration rights for Danone’s holdings.
On Stock Titan, Lifeway’s SEC filings are updated in step with the EDGAR system and paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly scan 8-K disclosures for governance and transaction developments, and refer to annual and quarterly reports when available for a broader view of Lifeway’s financial condition and risk factors, without having to interpret every technical section themselves.
LWAY insiders reported proposed and recent sales of Common Stock. A Form 144 lists Common Stock associated with Citigroup Global Markets Inc. The filing shows a historical gift of 750,000 shares on 03/09/2018 and recent dispositions by Edward Smolyansky of 22,313, 13,334 and 7,343 shares on 03/17/2026, 03/16/2026 and 03/11/2026 respectively, with cash proceeds recorded for each trade.
Ludmila Smolyansky submitted a Form 144 notice reporting proposed resale of 10,000 shares of Common Stock on 03/18/2026 through RBC Capital Markets LLC on Nasdaq. The filing also shows a prior sale of 26,431 shares on 12/23/2025 for $645,393.
Lifeway Foods, Inc. 10% owner Edward Smolyansky reported open-market sales of common stock. He sold 13,334 shares on March 16, 2026 at a weighted average price of $20.60 per share and 22,313 shares on March 17, 2026 at a weighted average price of $20.10 per share, for total reported sales of 35,647 shares. Following these transactions, he holds 1,115,995 shares directly. The filing also notes additional indirect holdings through a trust and an LLC, while shares held by a family foundation and by his son are specifically disclaimed for beneficial ownership.
Edward Smolyansky reported sales of Common Stock on behalf of a reporting person. The filing lists a sale of 13,334 shares on 03/16/2026 for $274,680.40 and a sale of 7,343 shares on 03/11/2026 for $155,010.73. The transactions are marked CASH and the securities are listed as Common Stock on NASDAQ.
Lifeway Foods reported a record 2025, with strong growth in sales and profits driven by its kefir business. Full-year net sales reached $212.5 million, up 13.7% year-over-year and about 19% on a comparable basis, marking six consecutive years of volume-led net sales growth. Gross profit margin for 2025 improved to 27.4% from 26.0%, while net income rose 54% to $13.9 million, or $0.89 per diluted share, compared with $0.60 a year earlier.
In the fourth quarter, net sales were $55.4 million, up 18.0% year-over-year, with gross margin expanding 250 basis points to 27.8%. The company generated quarterly net income of $2.5 million, or $0.16 per diluted share, versus a small loss in the prior-year quarter. Lifeway is investing in marketing, new products such as Lifeway Kefir Butter, and capacity while reiterating a long-term Adjusted EBITDA target of $45–$50 million for fiscal 2027.
Reporting persons filed a Form 144 reporting a sale of Common Stock related to LWAY. The filing shows a disposition of 7,343 shares on 03/11/2026 for $155,010.73. The record also notes a prior gift of 750,000 shares on 03/09/2018.
Lifeway Foods, Inc. reported that its Compensation Committee approved new forms for deferred cash awards under the company’s 2022 Omnibus Incentive Plan. These include a Notice of Deferred Time-Vested Cash Award and a Notice of Deferred Performance-Based Cash Award, which will govern how certain cash incentives are structured and deferred.
The two forms are provided as exhibits to the report, signaling a formal framework for both time-based and performance-linked deferred cash compensation for eligible participants under the plan.
Lifeway Foods, Inc. CFO Eric A. Hanson reported equity compensation and related tax withholding. On March 6, 2026, he received 2,672 restricted stock units and 21,396 shares of common stock at no cost, tied to previously granted performance share units whose performance goals were certified that day.
To cover tax obligations, 8,024 shares of common stock were surrendered to the company at $21.50 per share, with no stock sold on the market. After these transactions, Hanson directly owns 57,036 common shares and holds several blocks of restricted stock units scheduled to vest between June 16, 2026 and March 6, 2029, subject to continued service.